NASDAQ:MLND Millendo Therapeutics (MLND) Stock Price, News & Analysis → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free MLND Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.25▼$3.4550-Day Range$3.06▼$5.8452-Week Range$0.92▼$16.95Volume441,848 shsAverage Volume1.52 million shsMarket Capitalization$64.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Millendo Therapeutics alerts: Email Address Ad Market Moving TrendsTop 5 AI Stocks to Buy for 20245 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In" About Millendo Therapeutics Stock (NASDAQ:MLND)As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.Read More Ad Market Moving TrendsTop 5 AI Stocks to Buy for 20245 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In" MLND Stock News HeadlinesMarch 20, 2024 | msn.comA lifesaving therapy for children with a rare disease is now the world’s most expensive drug, raising questions about accessMarch 7, 2024 | msn.comMind Medicine sends psychedelic stocks higher after FDA status for LSD formulationJanuary 11, 2024 | markets.businessinsider.comClearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private PlacementDecember 5, 2023 | msn.comWhy Is Clearmind Medicine (CMND) Stock Up 50% Today?November 6, 2023 | markets.businessinsider.comMaxim Group Maintains Their Buy Rating on Mind Medicine (MMED)March 15, 2023 | benzinga.comExpert Ratings for Decibel TherapeuticsDecember 29, 2022 | insidermonkey.comIterum Therapeutics plc (NASDAQ:ITRM) Q3 2022 Earnings Call TranscriptDecember 29, 2022 | yahoo.comClearmind Medicine Announces Shareholders Meeting ResultsJune 3, 2022 | finance.yahoo.comClearmind Medicine Granted Patent Approval for Psychedelic- Based Alcohol Substitute in IndiaMay 31, 2022 | finance.yahoo.comDTx Pharma Appoints Michael Huang, MD as Chief Medical OfficerMay 19, 2022 | finance.yahoo.comClearmind Medicine Announces Successful Pre-Clinical Results in MEAI Treatment for Alcohol ConsumptionMay 16, 2022 | seekingalpha.comMind Medicine(MNMD) CEO Rob Barrow on Q1 2022 Results - Earnings Call TranscriptMay 15, 2022 | finance.yahoo.comClearmind Announces Pre-IND Meeting Date with FDASee More Headlines Receive MLND Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:MLND CUSIPN/A CIKN/A Webwww.millendo.com Phone734 845 9000FaxN/AEmployees12Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,410,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-91.03% Return on Assets-72.44% Debt Debt-to-Equity RatioN/A Current Ratio6.39 Quick Ratio6.39 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.78 per share Price / Book1.91Miscellaneous Outstanding Shares19,043,000Free FloatN/AMarket Cap$64.75 million OptionableNot Optionable Beta0.48 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key CompetitorsAileron TherapeuticsNASDAQ:ALRNMural OncologyNASDAQ:MURAViveon Health AcquisitionNYSE:VHAQLantern PharmaNASDAQ:LTRNAEON BiopharmaNASDAQ:AEONView All Competitors MLND Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Millendo Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Millendo Therapeutics investors own include Allena Pharmaceuticals (ALNA), Matinas BioPharma (MTNB), VYNE Therapeutics (VYNE), Acasti Pharma (ACST), Onconova Therapeutics (ONTX), TherapeuticsMD (TXMD), Bionano Genomics (BNGO), DURECT (DRRX), Geron (GERN) and Heat Biologics (HTBX). This page (NASDAQ:MLND) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport Societyis this a buy and hold stock?Tips4TradersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving TrendsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Millendo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
